Skip to search.
 TSX Up0.84% TSX Ventures 0.00%

Ligand Pharmaceuticals Incorporated (LGND)

-NGM

28.01 Up 1.32(4.95%) May 17, 4:00PM EDT|After Hours : 28.00 Down 0.01 (0.04%) May 17, 6:10PM EDT

Add to Portfolio
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period Ending2012-12-302011-12-302010-12-30
Net Income (527) 9,715   (10,373)
Operating Activities, Cash Flows Provided By or Used In
Depreciation2,727  1,088  510  
Adjustments To Net Income1,629  (7,802)5,592  
Changes In Accounts Receivables1,521  (3,915)(375)
Changes In Liabilities(6,168)(8,543)(20,100)
Changes In Inventories1,030  1,114   -  
Changes In Other Operating Activities849  5,469  (4,263)
Total Cash Flow From Operating Activities 161   (1,172) (27,067)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(595)(78)(70)
Investments10,000  9,346  18,456  
Other Cash flows from Investing Activities(8,142)(34,400)(3,846)
Total Cash Flows From Investing Activities 1,263   (25,132) 14,540  
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock6,416  (1)(68)
Net Borrowings(2,500)30,000  (91)
Other Cash Flows from Financing Activities -   -   -  
Total Cash Flows From Financing Activities 3,916   29,999   (159)
Effect Of Exchange Rate Changes -   -   -  
Change In Cash and Cash Equivalents 5,340   3,695   (12,686)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.